These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 9508372)

  • 1. Chemotherapy-induced apoptosis in melanoma cells is p53 dependent.
    Li G; Tang L; Zhou X; Tron V; Ho V
    Melanoma Res; 1998 Feb; 8(1):17-23. PubMed ID: 9508372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-dependent apoptosis in melanoma cells after treatment with camptothecin.
    Li G; Bush JA; Ho VC
    J Invest Dermatol; 2000 Mar; 114(3):514-9. PubMed ID: 10692111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53-stabilizing compound, CP-31398, does not enhance chemosensitivity in human melanoma cells.
    Luu Y; Li G
    Anticancer Res; 2003; 23(1A):99-105. PubMed ID: 12680200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells.
    Lai SL; Perng RP; Hwang J
    J Biomed Sci; 2000; 7(1):64-70. PubMed ID: 10644891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
    Fan S; Cherney B; Reinhold W; Rucker K; O'Connor PM
    Clin Cancer Res; 1998 Apr; 4(4):1047-54. PubMed ID: 9563901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance.
    Vasey PA; Jones NA; Jenkins S; Dive C; Brown R
    Mol Pharmacol; 1996 Dec; 50(6):1536-40. PubMed ID: 8967975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemosensitivity of human malignant glioma: modulation by p53 gene transfer.
    Trepel M; Groscurth P; Malipiero U; Gulbins E; Dichgans J; Weller M
    J Neurooncol; 1998 Aug; 39(1):19-32. PubMed ID: 9760067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis.
    Ho CK; Li G
    Br J Dermatol; 2005 Nov; 153(5):900-10. PubMed ID: 16225598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL; Ling YF; Lai MD
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines.
    Gibb RK; Taylor DD; Wan T; O'Connor DM; Doering DL; Gerçel-Taylor C
    Gynecol Oncol; 1997 Apr; 65(1):13-22. PubMed ID: 9103385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53 protein expression interferes with p53-independent apoptotic pathways.
    Li R; Sutphin PD; Schwartz D; Matas D; Almog N; Wolkowicz R; Goldfinger N; Pei H; Prokocimer M; Rotter V
    Oncogene; 1998 Jun; 16(25):3269-77. PubMed ID: 9681825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
    Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
    Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha.
    Mecchia M; Matarrese P; Malorni W; D'Agostino G; Sestili P; Santini SM; Gauzzi MC; Venditti M; Mazzocchi A; Parmiani G; Belardelli F; Ferrantini M
    Gene Ther; 2000 Jan; 7(2):167-79. PubMed ID: 10673721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.
    Raffo AJ; Kim AL; Fine RL
    Oncogene; 2000 Dec; 19(54):6216-28. PubMed ID: 11175336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of p53 mutant cisplatin-resistant ovarian carcinoma cells following drug exposure: spontaneously mutant selection.
    Righetti SC; Perego P; Corna E; Pierotti MA; Zunino F
    Cell Growth Differ; 1999 Jul; 10(7):473-8. PubMed ID: 10437915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.
    Bush JA; Cheung KJ; Li G
    Exp Cell Res; 2001 Dec; 271(2):305-14. PubMed ID: 11716543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status.
    Bartussek C; Naumann U; Weller M
    Exp Cell Res; 1999 Dec; 253(2):432-9. PubMed ID: 10585266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.